ClinConnect ClinConnect Logo
Search / Trial NCT06398041

Feasibility BFRT Geriatric Stroke Patients

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · May 2, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Geriatric Patients Geriatric Rehabilitation Blood Flow Restriction Training Physiotherapy Strength Training Stroke

ClinConnect Summary

This clinical trial is looking at the use of blood flow restriction training (BFRT) for older adults who have had a stroke. The goal is to see if this type of training is safe and tolerable for patients while they also receive standard physiotherapy. Over four weeks, participants will take part in BFRT sessions twice a week, guided by trained physiotherapists. The study will help determine how many patients are eligible for this program, how willing they are to participate, and the time commitment involved.

To be eligible, participants must be at least 65 years old, have recently suffered a stroke, and be stable enough to engage in rehabilitation. They should also be able to understand the exercises provided. However, those with certain health issues, like severe high blood pressure or infections, will not be included. If you or a loved one is considering participating, it’s important to know that the study aims to assess both the feasibility of this training and gather insights that might lead to larger studies in the future.

Gender

ALL

Eligibility criteria

  • A. Patients
  • Inclusion Criteria patients:
  • Patients admitted to the geriatric rehabilitation unit
  • ≥ 65years old
  • Medically stable as determined by the attending physician
  • Expecting at least 5 weeks of rehabilitation
  • Diagnosis of stroke (haemorrhagic/ischemic)
  • medical research council-scores of 2-3/5 for certain muscle groups
  • Being able to understand the exercises
  • signed informed consent
  • Exclusion Criteria:
  • Skin lesions located at the site of the cuff
  • Cognitive impairment making it impossible to understand the exercises
  • Severe comorbidities: (Deep Venous Thrombosis; Open wounds or infected wounds; Dialysis; Cancer; Severe High Blood pressure)
  • B. Healthcare workers:
  • Inclusion Criteria
  • being physiotherapist involved in the practical application of BFRT
  • signed informed consent

About Universitaire Ziekenhuizen Ku Leuven

Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.

Locations

Pellenberg, , Belgium

Patients applied

0 patients applied

Trial Officials

Jos Tournoy, MD

Principal Investigator

KU UZ Leuven

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported